InvestorsHub Logo
Followers 52
Posts 2230
Boards Moderated 0
Alias Born 07/06/2011

Re: frrol post# 2568

Monday, 11/14/2022 2:20:36 PM

Monday, November 14, 2022 2:20:36 PM

Post# of 3063
How time passes by so quickly. So many ups and downs in biotech, and "the science" is often very slow to play out, or at least for a company to prove they can sell something useful at a profit. Wish I would've learned to sell more on spikes we've had (though I did get my basis out here above $20). Any ways, just a follow up here regarding the possible cancer issue by NR:

insert-text-here

Lastly, we used BiNR to investigate the role of NR uptake in cancer prevalence and metastases formation in triple negative breast cancer (TNBC) animal model. Our results demonstrate that NR supplementation results in a significant increase in cancer prevalence and metastases of TNBC to the brain. These results outline the important role of powerful nutraceuticals like NR in cancer metabolism and the need to personalize their use in certain patient populations.



I don't know how to test this in the real world, except perhaps to do a case control study of those taking NR and looking at incidence of cancer.

It's possible the mouse M TNBC model does not apply to humans.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDXC News